VM Secures Major 46.2B KRW Supply Deal with SK Hynix; IVIM Tech Expands Biotech Reach

포스팅 대표 이미지

TL;DR

  • VM (formerly V-Technology) has landed a substantial 46.2 billion KRW ($34.5 million) semiconductor equipment contract with memory giant SK Hynix.
  • IVIM Technology announced a 500 million KRW ($373,000) export deal for its proprietary intravital microscopes with Paralab SA.
  • These KOSDAQ disclosures highlight the ongoing strength of the Korean semiconductor supply chain and the global niche expansion of its biotech equipment sector.

What Happened

On February 24, 2026, two notable disclosures were filed on the KOSDAQ market regarding new supply contracts:

  • VM (089890.KQ): The company announced a major contract to supply semiconductor manufacturing equipment to SK Hynix (000660.KS). The deal is valued at approximately 46.2 billion KRW (approx. $34.5 million). Given VM's scale, this contract represents a significant portion of its annual revenue and solidifies its role in the memory chip production cycle.
  • IVIM Technology (460050.KQ): The specialist in high-end medical imaging secured a 500 million KRW (approx. $373,000) contract with Paralab SA to supply its unique intravital microscopy systems. While the deal size is modest, it signifies continued international adoption of their specialized biotech hardware.

Korea Market Context

In the Korean market, specifically on the KOSDAQ, public disclosures (공시) regarding supply contracts are major price drivers for small and mid-cap stocks. For equipment manufacturers like VM, being a certified vendor for SK Hynix or Samsung Electronics—the two pillars of the Korean economy—is a mark of technical validation. Under Financial Supervisory Service (FSS) regulations, companies must disclose contracts that meet certain revenue thresholds, often leading to immediate volatility as investors price in future earnings visibility.

Investment Implications

For international investors, the VM deal is the more significant of the two. As SK Hynix continues its aggressive expansion in HBM (High Bandwidth Memory) and next-generation DRAM to meet AI demand, its domestic equipment partners are seeing a windfall. Investors should monitor whether this contract pertains to the latest production nodes, as this could signal recurring orders.

Regarding IVIM Technology, although the contract value is small, it demonstrates the company's ability to penetrate European markets. In the niche field of live-animal imaging, global expansion is key to scaling beyond the limited domestic research market. Both stocks represent the "pick and shovel" play of the Korean tech and biotech sectors, where growth is driven by the capital expenditures of larger global players.

Stocks Mentioned

  • VM (089890.KQ)
  • SK Hynix (000660.KS)
  • IVIM Technology (460050.KQ)

Popular posts from this blog

BTS Agency Clarifies Details of Upcoming Public Performance in Seoul

[속보] 한국은행 기준금리 연 2.5% '6회 연속' 동결! 고환율·집값에 갇힌 금리 인하 시계